Market Place
Sourcing Support
Caliway Unveils Multi-Mechanism Preclinical Research at TMASO
16 Dec 2025 //
PR NEWSWIRE
Cipla Introduces Yurpeak For Obesity, Type 2 Diabetes In India
10 Dec 2025 //
INDPHARMAPOST
Lilly looks to become innovation ‘backbone,’ exec says
08 Dec 2025 //
FIERCE BIOTECH
Eli Lilly Cuts Zepbound Price to Widen Access for Obesity Drug
01 Dec 2025 //
REUTERS
Ascletis Selects ASC37: First Oral Triple Agonist
30 Nov 2025 //
PR NEWSWIRE
Allurion Unveils Low-Dose Tirzepatide Combo Results
25 Nov 2025 //
BUSINESSWIRE
Lilly Redefines The Pharma Mega-Blockbuster
25 Nov 2025 //
BIOSPACE
India Considers Global Tenders For Key Patented Drugs Due
23 Nov 2025 //
ECONOMICTIMES
Eli Lilly Eyes Major Impact in Obesity, Diabetes
19 Nov 2025 //
ECONOMICTIMES
Eli Lilly, Novo Nordisk Strategize To Defend Top Obesity Drugs
18 Nov 2025 //
ECONOMICTIMES
Mangoceuticals Partners with Eli Lilly and Novo Nordisk
13 Nov 2025 //
GLOBENEWSWIRE
Mangoceuticals Clarifies Launch of Branded GLP-1 Programs
13 Nov 2025 //
GLOBENEWSWIRE
Trifecta Health, Trifecta Med Spa Enhance Weight Loss Treatment
11 Nov 2025 //
PR NEWSWIRE
Lilly Stitches `Queer Eye` Star Into Zepbound Campaign
11 Nov 2025 //
FIERCE PHARMA
Search For Next Blockbuster Drug Extends Beyond Weight Loss
10 Nov 2025 //
BIOSPACE
Ascletis Unveils Comprehensive Results Of ASC30 Studies
05 Nov 2025 //
PR NEWSWIRE
Needles, Pens & Pressure: The GLP-1 Challenge
05 Nov 2025 //
EXPRESSPHARMA
What`s Powering Mounjaro`s Rise To The Top Of Indian Drug Market
03 Nov 2025 //
ECONOMICTIMES
Lilly Blows Out Tirzepatide Sales Expectations, Raises Guidance
30 Oct 2025 //
FIERCE PHARMA
Lillydirect, Walmart Pharma Launch Retail Pick-Up For Zepbound
29 Oct 2025 //
PR NEWSWIRE
Lilly, Cipla Partner For Yurpeak Distribution In Weight Loss Drug
23 Oct 2025 //
ECONOMICTIMES
Medvi Expands Telehealth Access To Oral GLP-1 Tablets
14 Oct 2025 //
GLOBENEWSWIRE
Ascletis Selects Once-Monthly GLP-1R/GIPR Peptide ASC35
13 Oct 2025 //
PR NEWSWIRE
Aspen Wins Approval to Market Lilly`s Mounjaro in South Africa
13 Oct 2025 //
REUTERS
Eli Lilly`s Mounjaro Obesity Drug Achieves Strong India Sales
08 Oct 2025 //
ECONOMICTIMES
European Doctors Recommend Novo And Lilly Weight-Loss Drugs
02 Oct 2025 //
ECONOMICTIMES
Weight-Loss Drug Ozempic To Debut In India Soon
26 Sep 2025 //
ECONOMICTIMES
After Mounjaro, Eli Lilly Plans Weight loss Pill launch In India
19 Sep 2025 //
ECONOMICTIMES
Lilly`s Mounjaro Wins in Type 2 Diabetes Kids Trial 10-17
18 Sep 2025 //
FIERCE PHARMA
Lilly`s Mounjaro Helps Improve Blood Sugar Control in Children
17 Sep 2025 //
REUTERS
WHO Adds Popular Weight-Loss Drugs to Essential Medicines List
11 Sep 2025 //
ECONOMICTIMES
Novo, Lilly Obesity Drugs Deemed `Highly Cost-Effective` by ICER
09 Sep 2025 //
FIERCE PHARMA
WHO Includes GLP-1s in Essential Medicines List
08 Sep 2025 //
BIOSPACE
Europe Warns of Surge in Illegal Obesity Drugs
05 Sep 2025 //
FIERCE PHARMA
Novo’s Wegovy Cuts Risk of Heart Attack or Death by 57%
31 Aug 2025 //
GLOBENEWSWIRE
NHS Spends £1.92 Billion on Diabetes Treatment with New Meds
21 Aug 2025 //
PHARMAWEB
Novo to Showcase Wegovy & Ozempic Benefits at ESC Congress 2025
20 Aug 2025 //
GLOBENEWSWIRE
Ascletis` ASC47 & ASC31 Combo Shows Greater Weight Loss in Model
17 Aug 2025 //
PR NEWSWIRE
Lilly Launches Mounjaro KwikPen (tirzepatide) in India
15 Aug 2025 //
EXPRESSPHARMA
Eli Lilly to Raise Uk Price of Weight-Loss Drug Mounjaro by 170%
14 Aug 2025 //
BUSINESS STD
Enforcement Report - Week of August 13, 2025
13 Aug 2025 //
FDA
Ascletis ASC47 Shows Higher Efficacy With Tirzepatide In Obesity
12 Aug 2025 //
PR NEWSWIRE
Mounjaro measures up to Trulicity in Eli Lilly cardio trial
01 Aug 2025 //
FIERCE PHARMA
Obesity Drug Trials Underway in Big and Small Pharma Labs
31 Jul 2025 //
ECONOMICTIMES
Ascletis Starts US Ph2a Study for Obesity Drug ASC30
28 Jul 2025 //
PR NEWSWIRE
ET Graphics: Tirzepatide, Semaglutide lead India, misuse concerns
16 Jul 2025 //
ECONOMICTIMES
Palatin Reveals Preclinical Data for PL7737 in Obesity Model
15 Jul 2025 //
PR NEWSWIRE
Mounjaro Hits Rs 50 Cr Milestone in India as Wegovy Enters Market
08 Jul 2025 //
ECONOMICTIMES
Anti-obesity drug war heats up as Wegovy and Mounjaro boost sales
07 Jul 2025 //
BUSINESS STD
Remote Pharmacy updates availability of GLP-1 weight loss
03 Jul 2025 //
GLOBENEWSWIRE
Eli Lilly to roll out diabetes medicine in prefilled pen
27 Jun 2025 //
ECONOMICTIMES
Lilly Says India Response to Obesity Drug Mounjaro Is `positive`
20 Jun 2025 //
REUTERS
Scholar Rock`s Drug Helps Zepbound Patients Retain More Muscle
20 Jun 2025 //
REUTERS
Welldoc, Lilly Launch Personalized Platform for Incretin Patients
04 Jun 2025 //
BUSINESSWIRE
Zepbound outperforms Novo`s Wegovy for weight loss in trial
12 May 2025 //
REUTERS
Zepbound outperforms Wegovy in weight loss in Surmount-5 study
11 May 2025 //
PR NEWSWIRE
Mounjaro is now a heavyweight in weight-loss fight
08 May 2025 //
ECONOMICTIMES
SURPASS-3 Links Tirzepatide to Muscle Composition
01 May 2025 //
BUSINESSWIRE
WeightWatchers Simplifies Zepbound® Vial Access with LillyDirect
29 Apr 2025 //
GLOBENEWSWIRE
Lilly Sues 4 Compounders Over Copies of Weight-loss drugs
23 Apr 2025 //
REUTERS
